High Vista Strategies LLC Portfolio Holdings

High Vista Strategies LLC

  • $230 Million
  • Q1 2025

High Vista Strategies LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $230 Million distributed in 148 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Invesco Db Commodity Index Tracking Fund with a value of $32.3M, Hess Corp with a value of $4.62M, Juniper Networks Inc with a value of $4.15M, Albertsons Companies, Inc. with a value of $4.15M, and Ansys Inc with a value of $4.05M.

Examining the 13F form we can see an decrease of $11.8M in the current position value, from $242M to 230M.

High Vista Strategies LLC is based out at Boston, MA

Below you can find more details about High Vista Strategies LLC portfolio as well as his latest detailed transactions.

Portfolio value $230 Million
Healthcare: $87.3 Million
Technology: $43 Million
ETFs: $32.3 Million
Industrials: $16.7 Million
Consumer Cyclical: $16 Million
Financial Services: $11.5 Million
Consumer Defensive: $7.89 Million
Energy: $6.09 Million
Other: $7.24 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$179M
$797,000 0.35% of portfolio
212,185
Q3 2024 Reduced 14.4%
$39.8B
$791,000 0.34% of portfolio
12,456
Q1 2025 Added 20.28%
$4.69B
$732,000 0.32% of portfolio
2,211
Q3 2024 Reduced 12.75%
$664M
$624,000 0.27% of portfolio
85,241
Q4 2024 Added 31.09%
$15.9B
$544,000 0.24% of portfolio
3,850
Q1 2025 Reduced 20.26%
$202B
$561,000 0.24% of portfolio
1,800
Q1 2025 New
$1.12B
$561,000 0.24% of portfolio
39,020
Q1 2025 Reduced 15.39%
$389M
$530,000 0.23% of portfolio
52,107
Q3 2024 Added 32.9%
$2.59B
$482,000 0.21% of portfolio
13,328
Q1 2025 New
$52.8B
$459,000 0.2% of portfolio
11,183
Q1 2025 Added 3.71%
$606M
$431,000 0.19% of portfolio
53,374
Q1 2025 New
$1.64B
$402,000 0.17% of portfolio
8,942
Q4 2024 Reduced 34.11%
$345M
$384,000 0.17% of portfolio
33,305
Q3 2024 Added 4.49%
$570M
$339,000 0.15% of portfolio
31,942
Q4 2024 New
$542M
$357,000 0.15% of portfolio
22,768
Q3 2024 Added 35.93%
$3.42B
$332,000 0.14% of portfolio
5,212
Q1 2025 New
$399M
$241,000 0.1% of portfolio
31,893
Q3 2024 New
$8.07B
$228,000 0.1% of portfolio
11,900
Q1 2025 New
$2.61B
$239,000 0.1% of portfolio
8,733
Q4 2024 Reduced 31.47%
$445M
$222,000 0.1% of portfolio
23,941
Q4 2024 Added 48.91%
$589M
$202,000 0.09% of portfolio
127,284
Q3 2024 Reduced 29.21%
$192M
$185,000 0.08% of portfolio
135,667
Q4 2024 New
$79.8M
$148,000 0.06% of portfolio
109,938
Q1 2025 New
Brookfield Corp
-
$0 0.0% of portfolio
-
Q1 2025 New
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 32.48%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 58.46%
$23.9B
$0 0.0% of portfolio
-
Q1 2025 New
Core Scientific Inc New
-
$0 0.0% of portfolio
-
Q1 2025 Added 144.9%
Corbus Pharmaceuticals Hldgs
-
$0 0.0% of portfolio
-
Q3 2024 Added 94.09%
Abivax Sa
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 0.9%
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 41.76%
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 30.1%
Zymeworks Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Ge Vernova Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 44.12%
Qxo Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 12.01%
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 21.84%
Ncr Atleos Corporation
-
$0 0.0% of portfolio
-
Q1 2025 New
Magnera Corp
-
$0 0.0% of portfolio
-
Q1 2025 New
Kiniksa Pharmaceuticals Intl
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 15.84%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 29.4%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 9.67%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 44.63%
Ge Healthcare Technologies I
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 33.71%
Talen Energy Corp
-
$0 0.0% of portfolio
-
Q1 2025 Added 14.93%
Tko Group Holdings Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 17.12%
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 6.12%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q1 2025 Added 258.74%

Summary

  • Portfolio
  • No. of Stocks 148
  • Current Value $230 Million
  • Prior Value $242 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 35 stocks
  • Additional Purchases 39 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 27 stocks
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email